Skip to Content

Yuvvexy Approval Status

  • FDA approved: No
  • Brand name: Yuvvexy
  • Generic name: estradiol
  • Previous name: TX-004HR
  • Company: TherapeuticsMD, Inc.
  • Treatment for: Dyspareunia

Yuvvexy (estradiol) is an investigational bio-identical 17β-estradiol softgel capsule vaginal formulation for the treatment of dyspareunia (vaginal pain during sexual intercourse) due to menopause.

Development Status and FDA Approval Process for Yuvvexy

May  8, 2017TherapeuticsMD Receives Complete Response Letter from FDA for TX-004HR New Drug Application
Apr 19, 2017TherapeuticsMD Provides Additional Information on TX-004HR Regulatory Update
Apr 10, 2017TherapeuticsMD Provides TX-004HR Regulatory Update
Sep 19, 2016TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for Yuvvexy (TX-004HR)
Jul  7, 2016TherapeuticsMD Announces New Drug Application Submission for Yuvvexy (TX-004HR)

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.